Bank of Nova Scotia raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 347.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 84,254 shares of the medical instruments supplier's stock after buying an additional 65,426 shares during the quarter. Bank of Nova Scotia's holdings in DENTSPLY SIRONA were worth $1,259,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of XRAY. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of DENTSPLY SIRONA in the first quarter worth $25,000. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. True Wealth Design LLC increased its position in DENTSPLY SIRONA by 866.7% in the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after purchasing an additional 1,950 shares during the last quarter. Allworth Financial LP raised its stake in shares of DENTSPLY SIRONA by 175.8% during the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock worth $54,000 after purchasing an additional 2,517 shares in the last quarter. Finally, Quarry LP raised its stake in shares of DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the company. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target for the company. in a research note on Tuesday, April 15th. Barrington Research restated an "outperform" rating and set a $21.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, July 22nd. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Sunday, July 13th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Finally, UBS Group cut their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Ten equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $19.60.
Check Out Our Latest Analysis on XRAY
DENTSPLY SIRONA Price Performance
NASDAQ XRAY opened at $13.23 on Friday. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.48. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10. The stock has a market capitalization of $2.64 billion, a PE ratio of -2.91, a P/E/G ratio of 0.97 and a beta of 0.94. The stock has a 50-day simple moving average of $15.77 and a 200 day simple moving average of $15.96.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the prior year, the business earned $0.49 earnings per share. The firm's revenue for the quarter was down 4.9% on a year-over-year basis. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.
DENTSPLY SIRONA Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Stockholders of record on Friday, June 27th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.8%. The ex-dividend date of this dividend was Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.